Ethics and Editorial Policies

 | Post date: 2022/01/16 | 

Physiology and Pharmacology is committed to maintaining the highest level of integrity and transparency in the content published, and strictly adheres to the Committee on Publication Ethics (COPE) and Elsevier’s Publishing Ethics. Physiology and Pharmacology also endorses the recommendations provided by the Council of Science Editors  (CSE), and International Committee of Medical Journal Editors (ICMJE).
To ensure a fair and substantive assessment of submissions, Physiology and Pharmacology follow a double-blind peer review process. Every submitted manuscript within the scope of the journal will be reviewed by two or more specialists in the area of the submission. Physiology and Pharmacology reserve the right to reject a paper even after it has been accepted if it becomes apparent that there are serious problems with its scientific content, or its publishing policies have been violated.
Reviewers and authors are encouraged to study the journal’s ethics and editorial principles and abide by them:

Submission policies

When you submit a manuscript to Physiology and Pharmacology, we will take it to imply that the manuscript has not already been published or submitted elsewhere. You may not submit your manuscript elsewhere while it is under consideration at Physiology and Pharmacology.
Submitting a manuscript to Physiology and Pharmacology implies that all contributors listed as authors have read and agreed to the content of the submitted work and that the submission observes the policies of the journal.

Authorship policies

Each author listed in the manuscript is expected to have made substantial contributions in research process and manuscript creation. A contribution statement according to Contributor Roles Taxonomy (CRediT) needs to be submitted together with the manuscript where the role per author is described. This information is not currently published together with the article full text. Contributors who do not meet the criteria for authorship should be mentioned in the Acknowledgements. It is expected that those being acknowledged have given their permission to be named. 
Submission to Physiology and Pharmacology is taken by the journal to mean that all the listed authors have agreed all of the contents, including the author list and author contribution statements. All authors are responsible for scientific and ethical accuracy of the manuscript. Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. The corresponding author is responsible for having ensured that this agreement has been reached that all authors have agreed to be so listed, and have approved the manuscript submission to the journal. The corresponding author is responsible for managing all communication between the journal and all co-authors, before and after publication, and should submit the Author Agreement Form signed by all co-authors along with manuscript submission. 
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may also be stated. Physiology and Pharmacology remains neutral with regard to jurisdictional claims in institutional affiliations.
Any rearrangement, deletion or inclusion of authors might be requested only before the manuscript acceptance and will be effective if approved by the journal editor. To request such a change, a formal declaration from the corresponding author needs to be submitted to the editorial office, containing the reason for the change in author list in detail and written confirmation (academic e-mail, signed letter) from all authors that they agree with the changes. In the case of addition or removal of authors, the confirmation from the author being added or removed is also necessary. Only in exceptional circumstances will the editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the editor will result in a corrigendum.

Competing interests

Authors must disclose any competing financial and/or non-financial interests in relation to the work described, even when they are confident that their judgments have not been influenced in preparing the manuscript. Statements on competing interests have no influence on the editorial decision to publish. 
Examples of financial competing interests: (a) Financial research support by organizations (including salaries, equipment, supplies, and other expenses) that may gain or lose financially through this publication. A specific role for the funder in the creation of the manuscript should be disclosed. (b) Employment (while engaged in the research project or anticipated) by any organization that may gain or lose financially through this publication. (c) Personal financial interests including consultancies, stock ownership and patent applications/registrations that may gain or lose financially through publication. Non-financial competing interests can take different forms, including personal or professional relations with organizations and individuals. 

The corresponding author is responsible for submitting the conflict of interest declaration along with manuscript submission. Please refer to the Author Agreement Form.

Open access and copyright policies

The Physiology and Pharmacology has an open access policy that provides unrestricted access to all of its contents, immediately after publication. The Journalaims to improve access to research findings for all, and benefits its contributors by providing a broader readership.
Authors, who publish in Physiology and Pharmacology, agree to the following terms:

- The journal publishes only original materials that have not been previously published elsewhere.
- The articles published in the journal are subject to the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
- This license entitles all parties to copy, share, or redistribute the content published in this journal, without permission or fees, for non-commercial purposes, as long as the author(s) and original source are properly cited.
- Authors will transfer copyright to the Iranian Society of Physiology and Pharmacology (ISPP), by signing and submitting the Author Agreement Form  along with manuscript submission.
- The authors reserve all proprietary right other than copyright, and they will have the right to share their article in the same ways permitted to third parties under the CC BY-NC 4.0 license.
- All authors acknowledge that the copyright belongs to ISPP, under CC BY-NC 4.0 license conditions when their articles are published after passing the editorial and peer-review process.
With effect from January 1, 2024 onwards, Physiology and Pharmacology charges a publication fee to cover article-processing costs. All the accepted manuscripts (for submissions starting 1st January 2024, and except for “Letters to the Editor”) are required to pay the publication fee (20,000,000 IR Rials / 390 USD). Payment is due within 30 days of the manuscript receiving editorial acceptance. Physiology and Pharmacology provides up to a 50% waiver on manuscripts where the first author (25%) and/or corresponding author (25%) is a member of the Iranian Society of Physiology and Pharmacology at the time of manuscript acceptance. 

Ethics approval
All research data submitted to Physiology and Pharmacology that involve the use of animal or human subjects must have been performed according to accepted ethical standards and approved by an institutional and/or national research ethics committee.
Research involving human participants, human material, or human data, must have been performed in accordance with the Declaration of Helsinki. Research studies involving animals must have been performed in accordance with the Guide for the Care and Use of Laboratory Animals and comply with the ARRIVE guidelines.
Authors should include a statement that confirms that the study was reviewed and approved by the appropriate institutional and/or national research ethics committee, including the name of the ethics committee and the reference number where appropriate. If any exemption for requiring ethics approval has been granted for a study, the details including the name of the ethics committee should be stated in the manuscript.
Manuscripts may be rejected if the editors consider that the research has not been carried out within an appropriate ethical framework.

All articles submitted to Physiology and Pharmacology must cite appropriate and relevant peer-reviewed literature to address all statements relying on external sources of information. Author's own new ideas or findings or general knowledge do not need references.
The authors should ensure that their citations are accurate, and truly support the statements made in their manuscript.
Citing derivations of original work, citing review articles rather than original works, and excessive number of citations to support one point should be avoided.
Excessive self-citation, coordinated efforts among several authors to collectively self-cite, and any other form of citation manipulation are in appropriate and will result in the manuscript being rejected.

Preprint sharing
Preprints are defined as an author’s version of a research manuscript prior to formal peer review at a journal, which is deposited on a public server (as described in Preprints for the life sciences. Science 352, 899–901; 2016); preprints may be posted at any time during the peer review process.
Posting of preprints is not considered prior publication and will not jeopardize consideration at Physiology and Pharmacology.
Authors should disclose details of preprint posting, including DOI and licensing terms, upon submission of the manuscript or at any other point during consideration at Physiology and Pharmacology. Once the preprint is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.
Plagiarism as defined by ORI (Office of Research Integrity) imply the “theft or misappropriation of intellectual property and the substantial unattributed textual copying of another's work". Physiology and Pharmacology does not accept for consideration the manuscripts in which plagiarism is found. Authors must check their manuscript regarding plagiarism by the specialized service iThenticate and submit the similarity report file, along with manuscript submission. The manuscript will be considered for peer review process only if the similarity index be less than 20%.
The journal may use plagiarism detection software to screen the submissions at any point of processing. If plagiarism is identified, the COPE guidelines on plagiarism in a submitted manuscript or in a published article will be followed.
Duplicate publication is defined as submitting or publishing the same article, in more than one journal or using substantial parts of a previously published work without appropriate credit and citation. All manuscript submitted to Physiology and Pharmacology must be original and the manuscript, or substantial parts of it, must not has been published before or be under consideration by any other journal. Any cases of duplicate manuscript submission/publication will be handled as outlined in the COPE guidelines on duplicate publication in a submitted manuscript or in a published article and the editor may contact the authors’ institution.
The authors need to declare the sources of financial support for the conduct of the work submitted to Physiology and Pharmacology. It should be identified if the study funder(s) play a role in the study design; data collection, analysis and interpretation; writing of the manuscript; and decision to submit it for publication.
All manuscript submitted to Physiology and Pharmacology are initially checked by the editorial office to ensure that the submission has been properly completed and meets all the journal's technical requirements. The completed submissions will be assessed by the editor who decides whether they are in the scope of the journal and suitable for peer review. Every submitted manuscript, within the scope of the journal, will be sent for peer review to at least two appropriate independent experts. The journal follows a double-blind peer review process, where both referees and authors remain anonymous throughout the review process. Finally, the journal editor evaluates the peer reviewers' reports and makes the final decision to accept or reject the manuscript for publication or send it back to authors for revision.
Where the editor is on the author list or has any competing interest in a specific manuscript, a senior member of the editorial board will be assigned to evaluate peer review and make decision.
Content published in Physiology and Pharmacology is final and cannot be modified. In rare cases, the journal may issue addendum/erratum/corrigendum or retraction notice as updates on its peer-reviewed published content. The journal follows the COPE guidelines on retraction and handling of post publication critiques.
Addendum refers to providing additional information on a previously published article. Erratum implies to the correction of errors made by the publisher and corrigendum refers to the correction of errors made by the authors. Authors, readers or organizations who become aware of ethics issues or errors which affect the scientific integrity of the published article, are encouraged to contact the editorial office. Should the authors wish to add new material to their accepted article, they must submit a request to the editor and the new content will be reviewed, as a new manuscript. The editor determines the impact of the change and decides on the publication of the addendum, erratum or corrigendum. Addendum/erratum/corrigendum will be published with the title of “Addendum /Erratum/Corrigendum to [original article title]” in the paginated part of a subsequent issue of the journal.
In cases of infringements of publication ethics such as unethical research, unreliable data or findings, plagiarism, multiple submissions, claims of authorship, or the like, article retraction is mandatory. Articles may be retracted by their authors or by the journal editor, or jointly. Retractions will be published with the title of “Retraction Note to: [article title]” describing the reason for retraction, in the paginated part of a subsequent issue of the journal.
Crossmark is an initiative to provide a standard way for readers to locate the authoritative version of an article or other published content. By applying the Crossmark button, Physiology and Pharmacology is committing to maintain the content published and alert readers to changes if and when they occur.
Clicking the CrossMark logo on a document will inform the reader of the current status of a document and may also provide additional publication record information about the document.
Physiology and Pharmacology is committed to uphold the integrity of the literature and publishes corrections or retraction notices, where needed and in accordance with the COPE retraction guidelines. Correction or a retraction note will be bidirectionally linked to the original article.

DOI for Physiology and Pharmacology CrossMark Policy:   

View: 18772 Time(s)   |   Print: 1273 Time(s)   |   Email: 610 Time(s)   |   0 Comment(s)